ADAR3 activates NF-κB signaling and promotes glioblastoma cell resistance to temozolomide
Abstract The RNA binding protein ADAR3 is expressed exclusively in the brain and reported to have elevated expression in tumors of patients suffering from glioblastoma compared to adjacent brain tissue. Yet, other studies have indicated that glioblastoma tumors exhibit hemizygous deletions of the ge...
Main Authors: | Reshma Raghava Kurup, Eimile K. Oakes, Pranathi Vadlamani, Obi Nwosu, Pranav Danthi, Heather A. Hundley |
---|---|
Format: | Article |
Language: | English |
Published: |
Nature Portfolio
2022-08-01
|
Series: | Scientific Reports |
Online Access: | https://doi.org/10.1038/s41598-022-17559-4 |
Similar Items
-
ADAR-mediated regulation of PQM-1 expression in neurons impacts gene expression throughout C. elegans and regulates survival from hypoxia.
by: Ananya Mahapatra, et al.
Published: (2023-09-01) -
Glycosylated Delphinidins Decrease Chemoresistance to Temozolomide by Regulating NF-κB/MGMT Signaling in Glioblastoma
by: Diego Carrillo-Beltrán, et al.
Published: (2025-01-01) -
The C. elegans neural editome reveals an ADAR target mRNA required for proper chemotaxis
by: Sarah N Deffit, et al.
Published: (2017-09-01) -
ADARs regulate cuticle collagen expression and promote survival to pathogen infection
by: Alfa Dhakal, et al.
Published: (2024-02-01) -
NF-κB, Mesenchymal Differentiation and Glioblastoma
by: Bakhtiar Yamini
Published: (2018-08-01)